Pages that link to "Q615645"
Jump to navigation
Jump to search
The following pages link to Fabry disease (Q615645):
Displaying 50 items.
- migalastat (Q161613) (← links)
- Stéphane Hessel (Q165110) (← links)
- Gerald Uhlig-Romero (Q1510029) (← links)
- GLA (Q14886374) (← links)
- agalsidase beta (Q20801779) (← links)
- Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg (Q21004071) (← links)
- Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring (Q21202889) (← links)
- Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography (Q21245672) (← links)
- Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel (Q21261394) (← links)
- Fabry's crisis (Q21661017) (← links)
- Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease (Q22254862) (← links)
- Enzyme replacement therapy for Anderson-Fabry disease (Q24200877) (← links)
- Enzyme replacement therapy for Anderson-Fabry disease (Q24235483) (← links)
- Enzyme replacement therapy for Fabry disease (Q24244619) (← links)
- Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene (Q24304284) (← links)
- Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene (Q24319125) (← links)
- Long-term safety and efficacy of enzyme replacement therapy for Fabry disease (Q24533551) (← links)
- Fabry disease: isolation of a cDNA clone encoding human alpha-galactosidase A (Q24609101) (← links)
- Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene (Q24626162) (← links)
- Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease (Q24650910) (← links)
- Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease (Q24676955) (← links)
- Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. (Q24794000) (← links)
- Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease (Q24795877) (← links)
- Erratum to: Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients (Q24797962) (← links)
- Arterial wall properties and Womersley flow in Fabry disease (Q24803505) (← links)
- Enzyme replacement therapy for Anderson-Fabry disease (Q26471010) (← links)
- Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis (Q26745698) (← links)
- Electrocardiographic Changes and Arrhythmia in Fabry Disease (Q26751508) (← links)
- Pain management strategies for neuropathic pain in Fabry disease--a systematic review (Q26766561) (← links)
- Paediatric Fabry disease (Q26770283) (← links)
- Fabry disease, respiratory symptoms, and airway limitation - a systematic review (Q26777930) (← links)
- Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment (Q27010687) (← links)
- Molecular basis of 1-deoxygalactonojirimycin arylthiourea binding to human α-galactosidase a: pharmacological chaperoning efficacy on Fabry disease mutants (Q27690129) (← links)
- Fabry disease and the heart (Q27692646) (← links)
- Lipiduria--with special relevance to Fabry disease (Q28085337) (← links)
- A novel mutation of α-galactosidase A gene causes Fabry disease mimicking primary erythromelalgia in a Chinese family (Q28115455) (← links)
- Vascular complications of Fabry disease: enzyme replacement and other therapies (Q28175556) (← links)
- Gaucher's and Fabry's diseases: biochemical and genetic aspects (Q28205162) (← links)
- Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects (Q28205175) (← links)
- Point mutations in the upstream region of the ?-galactosidase A gene exon 6 in an atypical variant of Fabry disease (Q28210184) (← links)
- A case of Fabry's disease in a patient with no alpha-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser (Q28236442) (← links)
- Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey (Q28250905) (← links)
- Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey (Q28250923) (← links)
- Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry (Q28258153) (← links)
- Agalsidase alfa: a review of its use in the management of Fabry disease (Q28274194) (← links)
- An Atypical Variant of Fabry's Disease with Manifestations Confined to the Myocardium (Q28279249) (← links)
- Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature (Q28285817) (← links)
- Fabry disease (Q28299951) (← links)
- Enhanced endothelium-dependent vasodilation in Fabry disease (Q28343655) (← links)
- Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice (Q28345052) (← links)